6 June 2023FeaturesPatentsMuireann Bolger

UPC: Sanofi v Amgen lands front of queue at new court

The Unified Patent Court (UPC) may be less than a week old but it is already set to be the latest stage for the long-running dispute between Sanofi and Amgen concerning antibody patents.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Atif Choudhury at achoudhury@worldipreview.com

More on this story

Patents

UPC: The ‘sharp sword’ of global patent litigation

15 August 2023 After gaining momentum, are we now seeing the power posed by the court as a litigation forum, asks Antje Brambrink of Finnegan.

Patents

UPC announces late changes to opt-out functionality

10 March 2023 Unified Patent Court temporarily removes some functionality from opt-out system for ‘privacy and security’ reasons | New guidance also given on registration of representatives.

Patents

Breaking: UPC postponement 'the right thing to do'

5 December 2022 Sunrise period extended over concerns about access to court’s case management system | New period and start date announced by Klaus Grabinski and Johannes Karcher | Full details of new timings.

Ashurst Perkins Coie opens its doors following landmark merger

WIPO: We’re reaching a ‘critical mass’ on searchable, verified SEP data

Tata customers Apple and Tesla reportedly held to ransom after hack

UK court sets Warner and Paramount interim licence rate payable to Nokia

SpaceX launches into public orbit, but what now for its secretive IP strategy?

Bigger verdicts, fewer injunctions: AI, telecoms, and trade secrets shake up litigation

Disney hit by 11-country injunction over video streaming tech

Exclusive: ‘Cultural differences are an asset’ at the UPC

UPC: Sanofi v Amgen lands front of queue at new court

More on this story

Editor's picks

Editor's picks

More articles